CAM
SUPN icon

Congress Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Congress Asset Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,769
Closed -$317K – 402
2024
Q4 		$317K Sell
8,769
-225
-3% -$7.92K ﹤0.01% 359
2024
Q3 		$280K Sell
8,994
-87
-1% -$2.71K ﹤0.01% 348
2024
Q2 		$243K Sell
9,081
-1,023,060
-99% -$29.7M ﹤0.01% 359
2024
Q1 		$35.2M Buy
1,032,141
+111,333
+12% +$3.31M 0.25% 109
2023
Q4 		$26.6M Buy
920,808
+3,644
+0.4% +$96.6K 0.21% 116
2023
Q3 		$25.3M Buy
917,164
+147,105
+19% +$4.48M 0.22% 114
2023
Q2 		$23.1M Buy
770,059
+209,422
+37% +$7.33M 0.2% 114
2023
Q1 		$20.3M Buy
560,637
+53,846
+11% +$2.07M 0.19% 109
2022
Q4 		$18.1M Sell
506,791
-672
-0.1% -$23.4K 0.18% 100
2022
Q3 		$17.2M Buy
507,463
+25,921
+5% +$843K 0.18% 97
2022
Q2 		$13.9M Buy
481,542
+17,441
+4% +$500K 0.13% 117
2022
Q1 		$15M Buy
464,101
+67,996
+17% +$2.08M 0.13% 115
2021
Q4 		$11.6M Buy
396,105
+82,250
+26% +$2.5M 0.09% 153
2021
Q3 		$8.37M Buy
313,855
+19,074
+6% +$512K 0.07% 179
2021
Q2 		$9.08M Buy
+294,781
New +$9.04M 0.08% 162

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Congress Asset Management's SUPN Position: Q1 2025 in Review

Congress Asset Management sold out of Supernus Pharmaceuticals (SUPN) in Q1 2025, closing a stake of 8,769 shares — an estimated $317K sold.

Congress Asset Management first reported a position in SUPN in Q2 2021 and held it in 15 quarters. The position peaked at $35.2M in Q1 2024. 295 funds tracked by Wall St. Rank hold SUPN as of Q1 2025.

  • Congress Asset Management reported no remaining Supernus Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Congress Asset Management sold 8,769 Supernus Pharmaceuticals shares in Q1 2025, an estimated $317K.
  • Congress Asset Management first reported a position in Supernus Pharmaceuticals in Q2 2021 and held it in 15 quarters.
  • Congress Asset Management's Supernus Pharmaceuticals position peaked at $35.2M in Q1 2024.
  • 295 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2025.

Based on Congress Asset Management's 13F filing for Q1 2025, filed 11 Apr 2025.